CW
LTRN icon

Curio Wealth’s Lantern Pharma LTRN Stock Holding History

Curio Wealth’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74K Hold
2,000
– – ﹤0.01% 298
2025
Q4 		$6.68K Buy
+2,000
New +$7.45K ﹤0.01% 278
2025
Q3 		– Sell
-2,000
Closed -$6.32K – 329
2025
Q2 		$6.32K Buy
2,000
+1,999
+199,900% +$6.75K ﹤0.01% 226
2025
Q1 		$6.38K Sell
1
-1,999
-100% -$8.29K ﹤0.01% 257
2024
Q4 		$6.38K Buy
+2,000
New +$6.85K ﹤0.01% 235

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Curio Wealth's LTRN Position: Q1 2026 in Review

Curio Wealth held its Lantern Pharma (LTRN) position steady in Q1 2026 at 2,000 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Curio Wealth first reported a position in LTRN in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.68K in Q4 2025. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

  • Curio Wealth held 2,000 shares of Lantern Pharma worth $2.74K as of Q1 2026.
  • Curio Wealth left its Lantern Pharma share count unchanged in Q1 2026.
  • Lantern Pharma made up ﹤0.01% of Curio Wealth's portfolio in Q1 2026, its #298 holding.
  • Curio Wealth first reported a position in Lantern Pharma in Q4 2024 and has held it in 5 quarters since.
  • Curio Wealth's Lantern Pharma position peaked at $6.68K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Curio Wealth's 13F filing for Q1 2026, filed 12 May 2026.